XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Shares
Series A1
Preferred Shares
Series A2
Common Shares
Additional Paid-in Capital
Accumulated Earnings (Deficit)
Beginning balances at Dec. 31, 2019 $ 10,252 $ 7,546   $ 5,122 $ 2,300 $ (4,716)
Beginning balances, Shares at Dec. 31, 2019   2,105,264   151,681,382    
Issuance of Series A2 preferred shares 74,662   $ 74,662      
Issuance of Series A2 preferred shares, Shares     6,017,784      
Shares issued under stock option plan 124     $ 235 (111)  
Shares issued under stock option plan, Shares       535,000    
Stock-based compensation expense 744       744  
Net earnings (loss) (2,093)         (2,093)
Ending balances at Mar. 31, 2020 83,689 $ 7,546 $ 74,662 $ 5,357 2,933 (6,809)
Ending balances, Shares at Mar. 31, 2020   2,105,264 6,017,784 152,216,382    
Beginning balances at Dec. 31, 2020 830,508     $ 710,387 5,919 114,202
Beginning balances, Shares at Dec. 31, 2020       269,497,768    
Shares issued under stock option plan 173     $ 752 (579)  
Shares issued under stock option plan, Shares       1,428,162    
Stock-based compensation expense 4,021       4,021  
Reclassification of liability classified options 5,201       5,201  
Net earnings (loss) 117,221         117,221
Ending balances at Mar. 31, 2021 $ 957,124     $ 711,139 $ 14,562 $ 231,423
Ending balances, Shares at Mar. 31, 2021       270,925,930